» Articles » PMID: 35707125

Case Report: Primary Aldosteronism and Subclinical Cushing Syndrome in a 49-Year-Old Woman With Hypertension Plus Hypokalaemia

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coexisting primary aldosteronism (PA) and subclinical Cushing's syndrome (SCS) caused by bilateral adrenocortical adenomas have occasionally been reported. Precise diagnosis and treatment of the disease pose a challenge to clinicians due to its atypical clinical manifestations and laboratory findings.

Case Summary: A 49-year-old woman was admitted to our hospital due to fatigue, increased nocturia and refractory hypertension. The patient had a history of severe left hydronephrosis 6 months prior. Laboratory examinations showed hypokalaemia (2.58 mmol/L) and high urine potassium (71 mmol/24 h). Adrenal computed tomography (CT) showed bilateral adrenal masses. Undetectable ACTH and unsuppressed plasma cortisol levels by dexamethasone indicated ACTH-independent Cushing's syndrome. Although the upright aldosterone-to-renin ratio (ARR) was 3.06 which did not exceed 3.7, elevated plasma aldosterone concentrations (PAC) with unsuppressed PAC after the captopril test still suggested PA. Adrenal venous sampling (AVS) without adrenocorticotropic hormone further revealed hypersecretion of aldosterone from the right side and no dominant side of cortisol secretion. A laparoscopic right adrenal tumor resection was performed. The pathological diagnosis was adrenocortical adenoma. After the operation, the supine and standing PAC were normalized; while the plasma cortisol levels postoperatively were still high and plasma renin was activated. The patient's postoperative serum potassium and 24-h urine potassium returned to normal without any pharmacological treatment. In addition, the patient's blood pressure was controlled normally with irbesartan alone.

Conclusion: Patients with refractory hypertension should be screened for the cause of secondary hypertension. AVS should be performed in patients in which PA is highly suspected to determine whether there is the option of surgical treatment. Moreover, patients with PA should be screened for hypercortisolism, which can contribute to a proper understanding of the AVS result.

Citing Articles

The Entity of Connshing Syndrome: Primary Aldosteronism with Autonomous Cortisol Secretion.

Carsote M Diagnostics (Basel). 2022; 12(11).

PMID: 36428832 PMC: 9689802. DOI: 10.3390/diagnostics12112772.

References
1.
Ohara N, Kobayashi M, Yoneoka Y, Hasegawa G, Aoki Y, Nakamura Y . Primary Aldosteronism Presenting with Hypertension Five Days after Delivery: A Case Report and Literature Review. Intern Med. 2021; 61(4):507-512. PMC: 8907769. DOI: 10.2169/internalmedicine.7778-21. View

2.
Xu Z, Yang J, Hu J, Song Y, He W, Luo T . Primary Aldosteronism in Patients in China With Recently Detected Hypertension. J Am Coll Cardiol. 2020; 75(16):1913-1922. DOI: 10.1016/j.jacc.2020.02.052. View

3.
Zavatta G, Di Dalmazi G . Recent Advances on Subclinical Hypercortisolism. Endocrinol Metab Clin North Am. 2018; 47(2):375-383. DOI: 10.1016/j.ecl.2018.01.003. View

4.
Hannemann A, Wallaschofski H . Prevalence of primary aldosteronism in patient's cohorts and in population-based studies--a review of the current literature. Horm Metab Res. 2011; 44(3):157-62. DOI: 10.1055/s-0031-1295438. View

5.
Yasuda S, Hikima Y, Kabeya Y, Iida S, Oikawa Y, Isshiki M . Clinical characterization of patients with primary aldosteronism plus subclinical Cushing's syndrome. BMC Endocr Disord. 2020; 20(1):9. PMC: 6958814. DOI: 10.1186/s12902-020-0490-0. View